Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis. NLM AIDSLINE Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis.

Dig Dis Sci. 1999 Dec;44(12):2530-7. Unique Identifier : AIDSLINE MED/20094204
Perez-Machado MA; Espinosa LM; de la Madrigal EJ; Abreu L; Lorente GM; Alvarez-Mon M; University Department of Paediatric Gastroenterology, Royal Free; Hospital, London, UK.


Abstract: An abnormal immune response may play a pathogenic role in ulcerative colitis (UC). Animal models suggest that T-cell regulation may be of central importance in the inflammatory process. Our aims were the characterization of the phenotype and functional status of circulating T-cells in ulcerative colitis patients and to determine if activation-induced cell death in CD4 and CD8 lymphocytes in patients differs from healthy controls. Forty-eight patients (24 women and 24 men) fulfilling the histopathological, clinical, and immunological criteria for UC were studied. T-cell phenotype and function were studied in blood lymphocytes from patients with ulcerative colitis and healthy donors by flow cytometric analysis, as well as [3H]thymidine incorporation. There were no significant differences in the percentage of T-cell subpopulations (CD3, CD4, CD8) and NK cells in the different groups. The percentage of cells in growth phase S+G2M at two and three days of phytohemagglutinin (PHA) stimulation was significantly decreased in UC patients, but the percentage of CD4+ and CD8+ cells in UC patients that showed apoptosis was not significantly different than that in the control group. Proliferative responses to IL-4 also suggested that a reduced responsiveness to this cytokine may be involved in UC. In conclusion, the impaired proliferative response to PHA of T lymphocytes from UC patients is not associated with an in vitro increase in the apoptotic response in CD4+ or CD8+ cells. A reduced IL-4 response may be involved in this peculiar mitogenic response. These changes may be pathogenic or a favorable adaptive mechanism.


Keywords: JOURNAL ARTICLE Adult Aged Cell Death Cells, Cultured Colitis, Ulcerative/BLOOD/*IMMUNOLOGY CD4-Positive T-Lymphocytes/IMMUNOLOGY CD8-Positive T-Lymphocytes/IMMUNOLOGY Female Human Interleukin-4/PHARMACOLOGY Killer Cells, Natural/IMMUNOLOGY Lymphocyte Transformation Male Middle Age Mitosis T-Lymphocyte Subsets T-Lymphocytes/*IMMUNOLOGY/PATHOLOGY

KWDjournalarticleadultagedcelldeathcells,culturedcolitis,ulcerative/blood/KWDimmunologycd4-positivet-lymphocytes/immunologycd8-positivet-lymphocytes/immunologyfemalehumaninterleukin-4/pharmacologykillercells,natural/immunologylymphocytetransformationmalemiddleagemitosist-lymphocytesubsetst-lymphocytes/KWDimmunology/pathology
000430
A0040842


Copyright © 2000 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .